Xilio Development, Inc.
7Patents
7Active
7Granted
57Portfolio score
Filing activity: Dec 26, 2019 → Dec 28, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11053294B2 | Masked cytokine polypeptides | Chemistry; Metallurgy | 11 | Active |
| US12280120B2 | Tumor-specific cleavable linkers | Human Necessities | 0 | Active |
| US12384845B2 | Activatable masked anti-CTLA4 binding proteins | Chemistry; Metallurgy | 0 | Active |
| US11827686B2 | Masked cytokine polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11827685B2 | Masked cytokine polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11718655B2 | Masked interleukin-12 polypeptides | Chemistry; Metallurgy | 0 | Active |
| US11866476B2 | Masked IL-2-Fc fusion polypeptides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.